Food and Drug Administration (FDA): Response to Heparin Contamination Helped Protect Public Health; Controls That Were Needed Were Recently Added
DIANE Publishing, 2011 - 63 pages
In early 2008, the FDA responded to a crisis involving the contamination of heparin, a medication used to prevent and treat blood clots, when the agency received multiple reports of adverse events involving severe allergic reactions. The crisis took place from January 2008 through May 2008, during which time FDA took several actions in its response to the crisis. This report reviewed FDA's management of the heparin crisis. This report examines: (1) how FDA prevented additional contaminated heparin from reaching U.S. consumers; (2) how FDA coordinated its response to the contaminated heparin crisis; and (3) FDA's monitoring and analysis of adverse events associated with heparin. Charts and tables. This is a print on demand report.
What people are saying - Write a review
We haven't found any reviews in the usual places.
According to FDA adverse event reports adverse events associated AERS reports agency agency’s agency’s response allergic-type adverse events Analyses of Adverse Appendix associated with contaminated associated with heparin associated with heparin-containing Baxter heparin CDER China Chinese collaboration Containing Medical Devices contaminant in heparin contaminated heparin crisis crude heparin death reports deep vein thrombosis determine dialysis drug and device emergency external entities external scientists facilities FDA conducted FDA coordinated FDA data FDA identified FDA increased FDA officials told FDA took FDA’s Analyses FDA’s search term guidance Heparin and Heparin Heparin Associated heparin drug products heparin firms heparin manufacturers heparin products heparin sodium heparin supply heparin-containing medical devices investigations January LMWH manufacturing practices Marcia Crosse MAUDE reports MedDRA monitoring oedema OSCS contamination Oversulfated Chondroitin Sulfate patients pharmaceutical pruritus public health recall reports of adverse researchers search term criteria U.S. consumers United United States Pharmacopeia unknown contamination status